13:00-15:00 CET
Welcome and presentation of objectives of the webinar by Nevena Miletic (Roche), IFPMA Chair of CPP Network and Jyothsna Krishnan – Director, Regulatory Drug development & manufacturing at EFPIA.
Presentations:
- WHO’s recommendation for the use of eCPP – Samvel Azatyan – Team Lead, Regulatory Convergence and Networks at World Health Organization
- EMA’s practices and policies for issuing eCPP – Alberto Ganan Jimenez – Head of Procedures Office, Committees and Quality Assurance Department, European Medicines Agency (EMA)
- EDA’s lessons from the use of eCPPs – Maryam Ali Abdelmoneim – Egyptian Drug Authority, Box Inquiry Unit Manager in Administration of Registration
Panel discussion Q&A with representatives from WHO, EDA, EMA, MHRA
Final remarks by Patricia Salami – PhRMA MEA RA Group Chair (Merck KGaA)
3rd Oct 2022
13:00 - 15:00 UTC+01:00
Virtual webinar